Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$0.9 - $8.39 $179 - $1,669
-199 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$6.58 - $8.44 $1,039 - $1,333
158 Added 385.37%
199 $2,000
Q4 2021

Jan 14, 2022

SELL
$6.58 - $8.44 $1,039 - $1,333
-158 Reduced 79.4%
41 $2,000
Q3 2020

Oct 21, 2020

BUY
$4.79 - $6.3 $953 - $1,253
199 New
199 $1,000

Others Institutions Holding PRQR

About ProQR Therapeutics N.V.


  • Ticker PRQR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,362,096
  • Market Cap $191M
  • Description
  • ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...
More about PRQR
Track This Portfolio

Track Edge Wealth Management LLC Portfolio

Follow Edge Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Wealth Management LLC with notifications on news.